These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 8932840

  • 1. Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia.
    Boqué C, Petit J, Sarrá J, Cancelas JA, Muñoz J, Español JI, de la Banda E, Aventin A, Berlanga J, Ferrá C, Amill B, Torrico C, Azqueta C, Llucià M, García J, Grañena A.
    Bone Marrow Transplant; 1996 Nov; 18(5):879-84. PubMed ID: 8932840
    [Abstract] [Full Text] [Related]

  • 2. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM, Chimirri F, Podestà M, Pitto A, Piaggio G, Dejana A, Lerma E, Pollicardo N, Vassallo F, Soracco M, Benvenuto F, Valbonesi M, Carlier P, Vimercati R, Prencipe E, Gatti AM, Ferrara RA, Incagliato M, Florio G, Frassoni F.
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [Abstract] [Full Text] [Related]

  • 3. Preliminary results of stem cell mobilization in chronic myeloid leukemia with a moderate intensity chemotherapy regimen and G-CSF or G-CSF plus IL-3.
    Aulitzky WE, Neubauer A, Kolbe K, Schneller F, Busemann C, Schleiermacher E, Peschel C, Siegert W, Huber C, Huhn D.
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S67-9. PubMed ID: 8769707
    [Abstract] [Full Text] [Related]

  • 4. Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon.
    Hernández-Boluda JC, Carreras E, Cervantes F, Marín P, Arellano-Rodrigo E, Rovira M, Solé F, Lloveras E, Espinet B, Ocejo A, Montserrat E.
    Haematologica; 2002 Jan; 87(1):17-22. PubMed ID: 11801461
    [Abstract] [Full Text] [Related]

  • 5. Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosis.
    Sureda A, Petit J, Brunet S, Boqué C, Aventín A, Martino R, González JR, Amill B, Larriba I, Blanco A, Martín-Henao GA, Sierra J, Grañena A.
    Bone Marrow Transplant; 1999 Dec; 24(12):1285-90. PubMed ID: 10627636
    [Abstract] [Full Text] [Related]

  • 6. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia.
    Carella AM, Podesta M, Frassoni F, Raffo MR, Pollicardo N, Pungolino E, Vimercati R, Sessarego M, Parodi C, Rabitti C.
    Bone Marrow Transplant; 1993 Sep; 12(3):267-71. PubMed ID: 7694724
    [Abstract] [Full Text] [Related]

  • 7. Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilization.
    Olavarria E, Parker S, Craddock C, Philpott N, Tiniakou M, Chase A, Kanfer E, Apperley JF, Goldman JM.
    Haematologica; 2000 Jun; 85(6):647-52. PubMed ID: 10870123
    [Abstract] [Full Text] [Related]

  • 8. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
    Engelhardt M, Winkler J, Waller C, Lange W, Mertelsmann R, Henschler R.
    Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
    [Abstract] [Full Text] [Related]

  • 9. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G.
    Haematologica; 1997 Mar; 82(3):291-6. PubMed ID: 9234574
    [Abstract] [Full Text] [Related]

  • 10. Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemia.
    Mehta J, Mijović A, Powles R, Pagliuca A, Singhal S, Czepulkowski B, Swansbury GJ, Treleaven J, Mufti GJ.
    Bone Marrow Transplant; 1996 Jan; 17(1):25-9. PubMed ID: 8673050
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(-2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients.
    Watts MJ, Ings SJ, Leverett D, MacMillan A, Devereux S, Goldstone AH, Linch DC.
    Br J Cancer; 2000 Jan; 82(2):278-82. PubMed ID: 10646877
    [Abstract] [Full Text] [Related]

  • 14. Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma.
    Aurlien E, Holte H, Pharo A, Kvaløy S, Jakobsen E, Smeland EB, Kvalheim G.
    Bone Marrow Transplant; 1998 May; 21(9):873-8. PubMed ID: 9613778
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Peripheral blood stem cell collection in children with acute leukemia: effectiveness of the 'DIAVE' mobilizing regimen.
    Balduzzi A, Perseghin P, Dassi M, Bonanomi S, Rovelli A, Gaipa G, Biondi A, Uderzo C.
    Bone Marrow Transplant; 2002 Oct; 30(7):413-6. PubMed ID: 12368951
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negative Philadelphia chromosome].
    Meng FY, Sun J, Liu QF, Xu D, Yang LJ, Song LL, Liu XL, Xu B, Zhou SY.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1301-2, 1306. PubMed ID: 14678896
    [Abstract] [Full Text] [Related]

  • 20. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
    Weaver CH, Schulman KA, Buckner CD.
    Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.